Xiujie Liang

478 citations
18 papers · 359 indexed · h-index 11

Xiujie Liang

17 papers receiving 356 citations

Peers

Xiujie Liang
Comparison fields: 5 of 72
  • Nephrology 86
  • Clinical Biochemistry 42
  • Cancer Research 86
  • Cell Biology 41
  • Biochemistry 18
Replace J. Ignacio Herrero with:
J. Ignacio Herrero Spain
Changhui Diao China
Xiangxiao Li China
Jessica Tituaña Spain
Shuqin Mei China
Valeria Mannella Italy
Supriya Deshpande United States
Ranjan Das South Korea
Xiujie Liang relative to J. Ignacio Herrero Spain J. Ignacio Herrero's profile →
Citations per field
00.5×10×16×
J. Ignacio Herrero · 1×
Citations per year

Countries citing papers authored by Xiujie Liang

Since Specialization
Citations

This map shows the geographic impact of Xiujie Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujie Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujie Liang more than expected).

Fields of papers citing papers by Xiujie Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiujie Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujie Liang. The network helps show where Xiujie Liang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiujie Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiujie Liang Line = papers co-authored together Xiujie Liang links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20250
2 20251
3 20251
4 20246
5 202322
6 20225
7 202110
8 202154
9 202115
10 202023
11 201942
12 201948
13 201812
14 201643
15
[Arctiin ameliorates advanced oxidation protein product-induced epithelial-to- mesenchymal transition in HK-2 cells by inhibiting endoplasmic reticulum stress].
20161
16 201513
17 201536
18 201527

About Xiujie Liang

Xiujie Liang is a scholar working on Nephrology, Clinical Biochemistry and Parasitology, having authored 18 papers that have together received 359 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Advanced Glycation End Products research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), Renal and related cancers (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Vector-borne infectious diseases (2 papers). The work is most often cited by research in Nephrology (86 citations), Clinical Biochemistry (42 citations) and Cancer Research (86 citations). Xiujie Liang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Zhihong Yang, Xiu‐Fen Ming, Xun Tang, Tingting Guo, Yue Wang, Na Duan, Xiaohong Xiang, Shaojie Zhang, Katalin Suszták and Jun Zhang. Their work appears in journals such as Journal of Physiology and Biochemistry, Nature Communications, Frontiers in Physiology, Nature Genetics and Journal of Diabetes and its Complications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026